(Inclusive of all Taxes)
Get Free delivery (₹99)
Secure Payment
India's Most Trusted Pharmacy
Genuine Products
నిర్మాత/మార్కెటర్ :
స్కైసన్ లైఫ్ సైన్సెస్ ప్రైవేట్ లిమిటెడ్
వినియోగ రకం :
మౌఖిక
రిటర్న్ పాలసీ :
తిరిగి ఇవ్వబడదు
దీనికి ముద్ర లేదా తర్వాత గడువు ముగుస్తుంది :
Jan-27
Have a query?
Drug-Drug Interactions
Critical
Critical
Drug-Drug Interactions
Login/Sign Up
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Co-administration of Aliskiren with Telmijub AM-H 40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Co-administration of Aliskiren with Telmijub AM-H 40 Tablet can increase the risk of hyperkalemia (high potassium levels in the blood).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Aliskiren can possibly lead to an interaction, please consult a doctor before taking it. Do not discontinue the medications without consulting a doctor.
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Cisapride and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Telmijub AM-H 40 Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
Taking Cisapride and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Cisapride and Telmijub AM-H 40 Tablet together is generally avoided as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like dizziness, lightheadedness, fainting, or fast or pounding heartbeats, consult the doctor immediately. Do not stop using any medications without a doctor's advice.
HydrochlorothiazideDofetilide
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Dofetilide and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Telmijub AM-H 40 Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
Taking Dofetilide and Telmijub AM-H 40 Tablet can increase the risk of an irregular heart rhythm which can be severe. The risk increases in patients with a history of heart illness or electrolyte imbalance.
How to manage the interaction:
Combining Dofetilide and Telmijub AM-H 40 Tablet together is not recommended as it can possibly result in an interaction, it can be taken if advised by your doctor. However, if you experience any symptoms like sudden dizziness, lightheadedness, fainting, shortness of breath, chest pain or tightness, rapid heartbeat, or memory loss, contact your doctor immediately. Do not discontinue any medications without consulting a doctor.
AmlodipineDantrolene
Critical
How does the drug interact with Telmijub AM-H 40 Tablet:
Using Telmijub AM-H 40 Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
Using Telmijub AM-H 40 Tablet together with dantrolene may increase the risk of hyperkalemia (high blood potassium).
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with Dantrolene can cause an interaction, consult a doctor before taking it. You should seek medical attention if you experience nausea, vomiting, weakness, confusion, tingling of the hands and feet, a weak pulse, or a slow or irregular heartbeat. Do not stop using any medications without talking to a doctor.
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking spironolactone with Telmijub AM-H 40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking spironolactone with Telmijub AM-H 40 Tablet may increase potassium levels in the blood.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with spironolactone if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Coadministration of enalapril with Telmijub AM-H 40 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telmijub AM-H 40 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
Coadministration of enalapril with Telmijub AM-H 40 Tablet may increase the risk of hyperkalemia (high potassium levels in the blood), hypotension, syncope (fainting), and renal failure due to additive or synergistic effects. If you are elderly, dehydrated, or have a history of renal or heart illness, your risk is enhanced.
How to manage the interaction:
Although taking Enalapril together with Telmijub AM-H 40 Tablet may possibly result in an interaction, they can be taken together if prescribed by your doctor. However, contact your doctor immediately if you experience signs and symptoms of hyperkalemia, such as nausea, vomiting, confusion, numbness, tingling in hands and feet, and irregular heartbeat. It is advised to limit the intake of potassium-rich foods like tomatoes, bananas, papayas, mangoes, beans, and potassium-containing supplements. Do not discontinue any medication without consulting your doctor.
TelmisartanPotassium acetate
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Co-administration of Potassium acetate can make Telmijub AM-H 40 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Telmijub AM-H 40 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Co-administration of Potassium acetate can make Telmijub AM-H 40 Tablet more likely to cause high levels of potassium in the blood.
How to manage the interaction:
Although taking Potassium acetate and Telmijub AM-H 40 Tablet together can evidently cause an interaction, it can be taken if your doctor has suggested it. Do not stop using any medications without a doctor's advice.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Telmijub AM-H 40 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Taking Telmijub AM-H 40 Tablet with benazepril may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with benazepril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medication without consulting a doctor.
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking quinapril with Telmijub AM-H 40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
Taking quinapril with Telmijub AM-H 40 Tablet may increase the risk of side effects such as low blood pressure, kidney function impairment, and high blood potassium.
How to manage the interaction:
Although there is a possible interaction, Telmijub AM-H 40 Tablet can be taken with quinapril if prescribed by the doctor. Consult the prescriber if you experience symptoms of high potassium, such as nausea, vomiting, weakness, confusion, tingling of the hands and feet, feelings of heaviness in the legs, a weak pulse, or a slow or irregular heartbeat. Maintain adequate fluid intake during treatment with these medications. Do not discontinue the medications without consulting a doctor.
TelmisartanPotassium citrate
Severe
How does the drug interact with Telmijub AM-H 40 Tablet:
Taking Potassium citrate with Telmijub AM-H 40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telmijub AM-H 40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Taking Potassium citrate with Telmijub AM-H 40 Tablet together may increase potassium levels in the blood, which can lead to kidney failure, muscular paralysis, and abnormal heart rhythm.
How to manage the interaction:
Although taking Potassium citrate with Telmijub AM-H 40 Tablet together can possibly result in an interaction, it can be taken if a doctor has advised it. However, consult the doctor if you experience nausea, vomiting, weakness, disorientation, tingling in your hands and feet, feelings of heaviness in your legs, a weak pulse, or a slow or irregular heartbeat. It is essential to maintain proper fluid intake while taking these medications. It is advised to reduce the intake of potassium-rich foods. Do not discontinue any medications without a doctor's advice.
Drug-Food Interactions
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.50MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Drug-Food Interactions
Login/Sign Up
AMLODIPINE-5MG+HYDROCHLOROTHIAZIDE-12.50MG+TELMISARTAN-40MGPotassium rich foods
Moderate
Common Foods to Avoid:
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Telmijub AM-H 40 Tablet.
Lentils, Orange Juice, Oranges, Raisins, Potatoes, Salmon Dried, Spinach, Sweet Potatoes, Tomatoes, Coconut Water, Beans, Beetroot, Broccoli, Bananas, Apricots, Avocado, Yogurt
How to manage the interaction:
Taking Telmijub AM-H 40 Tablet with potassium-containing salt substitutes or potassium supplements can cause high levels of potassium in blood. Avoid taking potassium-containing salt substitutes or potassium supplements while being treated with Telmijub AM-H 40 Tablet.
మద్యం
అసురక్షిత
అసహ్యకరమైన దుష్ప్రభావాలను నివారించడానికి టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's తో పాటు మద్యం సేవించవద్దని మీకు సిఫార్సు చేయబడింది.
గర్భం
జాగ్రత్త
మీ వైద్యుడు దానిని అవసరమని భావించినప్పుడు తప్ప గర్భధారణ సమయంలో టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's సిఫార్సు చేయబడదు. మీకు సూచించే ముందు మీ వైద్యుడు ప్రయోజనాలను మరియు ఏవైనా సంభావ్య ప్రమాదాలను తూలనాడతారు.
ጡరు పాలు ఇస్తున్న
జాగ్రత్త
ጡరు పాలు ఇస్తున్న సమయంలో టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's సిఫార్సు చేయబడదు. అయితే, మీకు ప్రయోజనం ప్రమాదం కంటే ఎక్కువ అని అతను/ఆమె భావిస్తే, మీ వైద్యుడు ጡరు పాలు ఇస్తున్న సమయంలో మీకు సూచించవచ్చు. వైద్యుని సలహా లేకుండా మీరు టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's తీసుకోకూడదు.
డ్రైవింగ్
అసురక్షిత
ఇది సాధారణంగా మగతను కలిగిస్తుంది మరియు డ్రైవింగ్ సామర్థ్యాన్ని ప్రభావితం చేస్తుంది కాబట్టి టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's తీసుకున్న తర్వాత జాగ్రత్తగా డ్రైవ్ చేయాలని సూచించబడింది.
లివర్
జాగ్రత్త
ముఖ్యంగా మీకు లివర్ వ్యాధి ఉంటే లేదా చరిత్ర ఉంటే, టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's జాగ్రత్తగా తీసుకోవాలని సూచించబడింది. మీ వైద్య పరిస్థితి మరియు చికిత్సకు మీ ప్రతిస్పందనను బట్టి మీ వైద్యుడు మోతాదును మార్చవలసి ఉంటుంది.
కిడ్నీ
అసురక్షిత
దీర్ఘకాలిక మూత్రపిండ వ్యాధి (తీవ్రమైన మూత్రపిండాల లోపం) ఉన్న రోగులకు ఇది సిఫార్సు చేయబడదు. తీవ్రమైన మూత్రపిండాల లోపం ఉన్న రోగులలో భద్రత మరియు ప్రభావం స్థాపించబడలేదు.
పిల్లలు
జాగ్రత్త
టెల్మిజబ్ AM-H 40 టాబ్లెట్ 10's కోసం తగినంత శాస్త్రీయ డేటా అందుబాటులో లేదు, కాబట్టి పిల్లల నిపుణుడిని సంప్రదించడం ఉత్తమం.
Disclaimer
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
Author Details
